Content about Teva Pharmaceutical Industries

June 6, 2010
On top of generics industry losses, GPhA loses CEO

After nearly a decade at the helm, Generic Pharmaceutical Association president and CEO Kathleen Jaeger...

June 2, 2010
Teva launches Differin generic

The Food and Drug Administration has approved a new generic acne treatment made by Teva...

May 31, 2010
Teva launches generic Yaz

Teva Pharmaceutical Industries has launched a generic oral contraceptive, the drug maker said Tuesday....

May 24, 2010
Generic Valtrex to hit the market

Teva Pharmaceuticals has introduced a generic version of a drug for genital herpes, shingles and...

May 24, 2010
Report: Teva recruits patients for Rituxan biosimilar trial

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 17, 2010
AstraZeneca allows Teva to market generic Entocort EC

Teva Pharmaceutical Industries and AstraZeneca have reached a settlement that will allow Teva to market...

May 17, 2010
Teva: Enjuvia may reduce nighttime awakenings in postmenopausal women

A branded drug made by Teva Pharmaceutical Industries reduced the frequency of nighttime awakenings due...

May 16, 2010
Teva: Lou Gehrig’s disease treatment trial did not meet endpoints

An investigational drug made by Teva Pharmaceutical Industries was not effective in patients with Lou...

May 13, 2010
Report: Teva may benefit from health-reform law

Teva Pharmaceutical Industries could get a lot of business thanks to the health-reform law, according...

May 13, 2010
Teva receives tentative approval for generic Sensipar

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical Industries’ generic version...

May 3, 2010
Copaxone sales raise Teva's Q1 profit

Teva Pharmaceutical Industries had net sales of $3.7 billion in first quarter 2010, a 16%...

May 3, 2010
GPhA president, CEO resigns

Generic Pharmaceutical Association president and CEO Kathleen Jaeger will leave the organization effective June 30,...

March 17, 2010
Teva to acquire Ratiopharm

Teva Pharmaceutical Industries beat out Pfizer in the race to acquire German generic drug maker...

March 16, 2010
Pending court ruling, Teva to delay marketing Temodar generic

Teva Pharmaceutical Industries will start marketing its version of a brain tumor drug only if...

March 15, 2010
Teva seeks to market Shire's ADHD drug

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

March 8, 2010
Teva names Frost new chairman of the board

The world’s largest maker of generic drugs has appointed a new chairman....

March 4, 2010
Mylan gets upgrade from Moody's

Generic drug maker Mylan got an upgrade in its credit rating from Moody’s Investors Service,...

March 2, 2010
Pfizer may buy Ratiopharm

It appears that Pfizer has changed its mind a second time about buying Ratiopharm....

March 1, 2010
Court: Teva to receive market exclusivity for generic Hyzaar, Cozaar

The U.S. Court of Appeals for the District of Columbia has overturned a district court...

February 28, 2010
The biggest Little Pharma in the world

With exception to those companies that are the first to win Food and Drug Administration...

February 16, 2010
Teva full-year profits up 22%

Teva Pharmaceutical Industries got a big boost in profits in 2009 compared with 2008, the...

February 7, 2010
Teva settles drug price inflation lawsuit

Teva Pharmaceutical Industries has reached a settlement in a case alleging that governments had to...

February 1, 2010
FDA accepts approval application for Teva's Neutroval

The Food and Drug Administration has accepted a regulatory approval application from Teva Pharmaceutical Industries...

January 31, 2010
Teva files ANDA for generic version of HIV drug

Teva is hoping to release its version of an HIV drug before the drug’s patents...

January 27, 2010
Teva UK launches generic eye treatment

The British subsidiary of Teva Pharmaceutical Industries has launched a treatment for intra-ocular pressure resulting...

© 2013 Drug Store News. All Rights Reserved.